Baidu
map

Post-remission measurable residual disease directs treatment choice and improves outcomes for patients with intermediate-risk acute myeloid leukemia in CR1

Han, LJ; Li, YL; Wu, JY; Peng, J; Han, XL; Zhao, HM; He, C; Li, YY; Wang, WM; Zhang, MM; Li, YF; Sun, H; Cao, HX; Sang, LN; Jiang, ZX; Yu, JF

Han, LJ; Yu, JF (通讯作者),Zhengzhou Univ, Affiliated Hosp 1, Dept Hematol, Zhengzhou, Peoples R China.

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022; 116 (6): 892

Baidu
map
Baidu
map
Baidu
map